Diaminopyrimidines as P2X3 and P2X2/3 antagonists
US8846705B2 · kind B2 · utility
4Cited by
45References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2010 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Dec 8, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/506
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I):or a pharmaceutically acceptable salt, solvate or prodrug thereof,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.